The anti-inflammatory and immune-modulatory effects of OEA limit DSS-induced colitis in mice.

CONCLUSIONS AND IMPLICATIONS: These results underscore the validity of OEA as a potent protective and anti-inflammatory agent in ulcerative colitis that may be exploited to broaden the pharmacological strategies against inflammatory bowel disease.
PMID: 32559625 [PubMed - as supplied by publisher]

Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - June 14, 2020 Category: Drugs & Pharmacology Authors: Lama A, Provensi G, Amoriello R, Pirozzi C, Rani B, Mollica MP, Raso GM, Ballerini C, Meli R, Passani MB Tags: Biomed Pharmacother Source Type: research